Pharmacist's Letter Canada | Convenient Monthly Updates + CE

Current Issue

September 2025 Issue

Stay Current on the Latest Smoking Cessation Guidance

You’ll see renewed focus on smoking cessation...

Resources

Chart: Smoking Cessation Drug Therapy

Watch for Baloxavir for Influenza Treatment

Baloxavir (Xofluza) will be the latest antiviral in our arsenal to treat influenza in patients 12 years and up...

Expect More Oral Antibiotics for Bone and Joint Infections

You’ll see renewed focus on using highly bioavailable ORAL antibiotics for bone and joint infections in adults...

Sort Through Options to Prevent VTE After Orthopedic Surgery

You’ll field questions about preventing venous thromboembolism (VTE) after orthopedic surgery...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Supplements of Abuse: Unmasking Potential Risks

CE-IN-THE-LETTER: Pharmacist's Letter Canada September 2025

LIVE CE: Pharmacy Essential Updates September 2025

PODCAST CE: Medication Talk - Implicit Bias in Healthcare

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information